PROCASTAT

Welcome to the Brand page for “PROCASTAT”, which is offered here for Gene therapy products, pharmaceutical preparation vectors for use in gene therapy, clinical medical reagents, therapeutic compositions containing vectors for gene therapy for use in the treatment of cancer, neurological, ocular, hearing, balance and auto-immune disorders; enzymes and enzyme preparations for gene therapy purposes, retroviral vector and retroviral vector manufacturing preparations, all for the field of gene therapy, for the treatment of prostate cancer;instruments and apparatus for the administration of gene therapy products; surgical and medical apparatus and instruments;.

Its status is currently believed to be active. Its class is unavailable. “PROCASTAT” is believed to be currently owned by “Oxford BioMedica plc”.


Owner:
OXFORD BIOMEDICA PLC
Owner Details
Description:
Gene therapy products, pharmaceutical preparation vectors for use in gene therapy, clinical medical reagents, therapeutic compositions containing vectors for gene therapy for use in the treatment of cancer, neurological, ocular, hearing, balance and auto-immune disorders; enzymes and enzyme preparations for gene therapy purposes, retroviral vector and retroviral vector manufacturing preparations, all for the field of gene therapy, for the treatment of prostate cancer;Instruments and apparatus for the administration of gene therapy products; surgical and medical apparatus and instruments;
Categories: GENE THERAPY PRODUCTS